This effect has been described in lung and cervical cancer cells in the case of EIF4E-BP2, which encodes a negative regulator of eukaryotic translation initiation factor 4E (eIF4E) (Mizutani et al., 2016), and miR145-5p in breast cancer (Samanta et al., 2018). This evidence concerns the gene EIF4E and breast cancer.